- Home
- PTEN vs ARQT Comparison
PTEN vs ARQT Comparison
Compare PTEN & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTEN
- ARQT
- Stock Information
- Founded
- PTEN 1978
- ARQT 2016
- Country
- PTEN United States
- ARQT United States
- Employees
- PTEN N/A
- ARQT N/A
- Industry
- PTEN Oil & Gas Production
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- PTEN Energy
- ARQT Health Care
- Exchange
- PTEN Nasdaq
- ARQT Nasdaq
- Market Cap
- PTEN 2.5B
- ARQT 2.1B
- IPO Year
- PTEN 1993
- ARQT 2020
- Fundamental
- Price
- PTEN $5.97
- ARQT $25.15
- Analyst Decision
- PTEN Buy
- ARQT Strong Buy
- Analyst Count
- PTEN 10
- ARQT 7
- Target Price
- PTEN $7.35
- ARQT $22.17
- AVG Volume (30 Days)
- PTEN 10.2M
- ARQT 2.8M
- Earning Date
- PTEN 10-22-2025
- ARQT 10-28-2025
- Dividend Yield
- PTEN 5.35%
- ARQT N/A
- EPS Growth
- PTEN N/A
- ARQT N/A
- EPS
- PTEN N/A
- ARQT N/A
- Revenue
- PTEN $4,837,946,000.00
- ARQT $317,929,000.00
- Revenue This Year
- PTEN N/A
- ARQT $85.27
- Revenue Next Year
- PTEN N/A
- ARQT $30.70
- P/E Ratio
- PTEN N/A
- ARQT N/A
- Revenue Growth
- PTEN N/A
- ARQT 129.21
- 52 Week Low
- PTEN $5.10
- ARQT $8.90
- 52 Week High
- PTEN $9.58
- ARQT $27.08
- Technical
- Relative Strength Index (RSI)
- PTEN 48.58
- ARQT 62.46
- Support Level
- PTEN $5.88
- ARQT $23.32
- Resistance Level
- PTEN $6.56
- ARQT $24.39
- Average True Range (ATR)
- PTEN 0.28
- ARQT 1.63
- MACD
- PTEN -0.06
- ARQT -0.15
- Stochastic Oscillator
- PTEN 28.31
- ARQT 62.80
About PTEN Patterson-UTI Energy Inc.
Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.